FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2912058326> ?p ?o ?g. }

• W2912058326 endingPage "385" @default.
• W2912058326 startingPage "385" @default.
• W2912058326 abstract "To compare the safety and efficacy of radioembolization with that of sorafenib for the treatment of hepatocellular carcinoma (HCC) with portal vein tumor thrombosis (PVTT).MEDLINE, EMBASE, and Cochrane databases were searched for studies reporting outcomes in patients with HCC and PVTT treated with radioembolization or sorafenib. Meta-analyses of cumulative overall survival (OS) and Kaplan-Meier survival rates according to the time to progression (TTP) and incidence of adverse events (AEs) were performed. Subgroup analyses were conducted on 1-year OS data.Seventeen studies were identified (four involving radioembolization, 10 involving sorafenib, and three comparing both). Pooled OS rates were higher in the radioembolization group, notably at 6 months {76% (95% confidence interval [CI], 64-85%) vs. 54% (95% CI, 45-62%)} and 1 year (47% [95% CI, 38-57%] vs. 24% [95% CI, 18-30%]); TTP was also longer with radioembolization. In patients undergoing radioembolization, the proportion of patients with Eastern Cooperative Oncology Group status 0 (p < 0.0001), Child-Pugh A (p < 0.0001), extrahepatic metastasis (p = 0.0012), and a history of cancer treatment (p = 0.0048) was identified as a significant source of heterogeneity for the 1-year OS. Radioembolization was associated with a lower incidence of grade 3/4 AEs than sorafenib (9% [95% CI, 3-27%] vs. 28% [95% CI, 17-43%]).Compared with sorafenib, radioembolization is a safer and more effective treatment for HCC with PVTT and is associated with prolonged survival, delayed tumor progression, and fewer grade 3/4 AEs." @default.
• W2912058326 created "2019-02-21" @default.
• W2912058326 creator A5000290016 @default.
• W2912058326 creator A5009479126 @default.
• W2912058326 creator A5066903646 @default.
• W2912058326 creator A5090333957 @default.
• W2912058326 date "2019-01-01" @default.
• W2912058326 modified "2023-10-03" @default.
• W2912058326 title "Comparison of Radioembolization and Sorafenib for the Treatment of Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis: A Systematic Review and Meta-Analysis of Safety and Efficacy" @default.
• W2912058326 cites W1948056189 @default.
• W2912058326 cites W1971837077 @default.
• W2912058326 cites W1979809642 @default.
• W2912058326 cites W1990295946 @default.
• W2912058326 cites W1994193851 @default.
• W2912058326 cites W2004357387 @default.
• W2912058326 cites W2012932483 @default.
• W2912058326 cites W2016199951 @default.
• W2912058326 cites W2018597711 @default.
• W2912058326 cites W2027117783 @default.
• W2912058326 cites W2051193106 @default.
• W2912058326 cites W2068666196 @default.
• W2912058326 cites W2072426278 @default.
• W2912058326 cites W2077421021 @default.
• W2912058326 cites W2114029473 @default.
• W2912058326 cites W2138152245 @default.
• W2912058326 cites W2163403599 @default.
• W2912058326 cites W2163557371 @default.
• W2912058326 cites W2166108782 @default.
• W2912058326 cites W2178658282 @default.
• W2912058326 cites W2279273926 @default.
• W2912058326 cites W2341904425 @default.
• W2912058326 cites W2346328604 @default.
• W2912058326 cites W2467567502 @default.
• W2912058326 cites W2540473324 @default.
• W2912058326 cites W2582878252 @default.
• W2912058326 cites W2597575764 @default.
• W2912058326 cites W2610193101 @default.
• W2912058326 cites W2625856057 @default.
• W2912058326 cites W2753753279 @default.
• W2912058326 cites W2765356289 @default.
• W2912058326 cites W2782800784 @default.
• W2912058326 cites W2783339964 @default.
• W2912058326 cites W2791082369 @default.
• W2912058326 cites W2791703762 @default.
• W2912058326 cites W2793119715 @default.
• W2912058326 cites W2839856130 @default.
• W2912058326 cites W2889646458 @default.
• W2912058326 cites W3022903699 @default.
• W2912058326 cites W4245784696 @default.
• W2912058326 doi "https://doi.org/10.3348/kjr.2018.0496" @default.
• W2912058326 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6389804" @default.
• W2912058326 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30799569" @default.
• W2912058326 hasPublicationYear "2019" @default.
• W2912058326 type Work @default.
• W2912058326 sameAs 2912058326 @default.
• W2912058326 citedByCount "25" @default.
• W2912058326 countsByYear W29120583262019 @default.
• W2912058326 countsByYear W29120583262020 @default.
• W2912058326 countsByYear W29120583262021 @default.
• W2912058326 countsByYear W29120583262022 @default.
• W2912058326 countsByYear W29120583262023 @default.
• W2912058326 crossrefType "journal-article" @default.
• W2912058326 hasAuthorship W2912058326A5000290016 @default.
• W2912058326 hasAuthorship W2912058326A5009479126 @default.
• W2912058326 hasAuthorship W2912058326A5066903646 @default.
• W2912058326 hasAuthorship W2912058326A5090333957 @default.
• W2912058326 hasBestOaLocation W29120583261 @default.
• W2912058326 hasConcept C120665830 @default.
• W2912058326 hasConcept C121332964 @default.
• W2912058326 hasConcept C126322002 @default.
• W2912058326 hasConcept C143998085 @default.
• W2912058326 hasConcept C197934379 @default.
• W2912058326 hasConcept C2778019345 @default.
• W2912058326 hasConcept C2778695046 @default.
• W2912058326 hasConcept C2778800853 @default.
• W2912058326 hasConcept C2780868729 @default.
• W2912058326 hasConcept C44249647 @default.
• W2912058326 hasConcept C61511704 @default.
• W2912058326 hasConcept C71924100 @default.
• W2912058326 hasConcept C72563966 @default.
• W2912058326 hasConcept C88879693 @default.
• W2912058326 hasConcept C95190672 @default.
• W2912058326 hasConceptScore W2912058326C120665830 @default.
• W2912058326 hasConceptScore W2912058326C121332964 @default.
• W2912058326 hasConceptScore W2912058326C126322002 @default.
• W2912058326 hasConceptScore W2912058326C143998085 @default.
• W2912058326 hasConceptScore W2912058326C197934379 @default.
• W2912058326 hasConceptScore W2912058326C2778019345 @default.
• W2912058326 hasConceptScore W2912058326C2778695046 @default.
• W2912058326 hasConceptScore W2912058326C2778800853 @default.
• W2912058326 hasConceptScore W2912058326C2780868729 @default.
• W2912058326 hasConceptScore W2912058326C44249647 @default.
• W2912058326 hasConceptScore W2912058326C61511704 @default.
• W2912058326 hasConceptScore W2912058326C71924100 @default.
• W2912058326 hasConceptScore W2912058326C72563966 @default.
• W2912058326 hasConceptScore W2912058326C88879693 @default.
• W2912058326 hasConceptScore W2912058326C95190672 @default.
• W2912058326 hasIssue "3" @default.

• next